CLINICAL PSYCHOPHARMACOLOGY MAY BENEFIT FROM NEW ADVANCES IN 5-HT PHARMACOLOGY

被引：11

作者：

COOPER, SJ

ABBOTT, A

机构：

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1988年 / 9卷 / 08期

关键词：

D O I：

10.1016/0165-6147(88)90001-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：269 / 271

页数：3

共 8 条

[1] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].

BRADLEY, PB ;

ENGEL, G ;

FENIUK, W ;

FOZARD, JR ;

HUMPHREY, PPA ;

MIDDLEMISS, DN ;

MYLECHARANE, EJ ;

RICHARDSON, BP ;

SAXENA, PR .

NEUROPHARMACOLOGY, 1986, 25 (06) :563-576

[2]

BUTTER C M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P525

[3] THE INFLUENCE OF RITANSERIN, A SEROTONIN ANTAGONIST, IN ANXIETY DISORDERS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY VERSUS LORAZEPAM [J].

CEULEMANS, DLS ;

HOPPENBROUWERS, MLJA ;

GELDERS, YG ;

REYNTJENS, AJM .

PHARMACOPSYCHIATRY, 1985, 18 (05) :303-305

[4] ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].

CHOPIN, P ;

BRILEY, M .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388

[5] 5-HT3 RECEPTORS AND CYTOTOXIC DRUG-INDUCED VOMITING [J].

FOZARD, JR .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (02) :44-45

[6]

Gray JA., 1987, NEUROPSYCHOLOGY ANXI

[7]

RAPPORT MM, 1949, J BIOL CHEM, V180, P961

[8] PHARMACOLOGICAL AND CLINICAL EFFECTS OF BUSPIRONE [J].

TAYLOR, DP ;

EISON, MS ;

RIBLET, LA ;

VANDERMAELEN, CP .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 23 (04) :687-694

← 1 →